Current Practical Applications of Diagnostic Immunohistochemistry in Breast Pathology
- 1 August 2004
- journal article
- review article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 28 (8) , 1076-1091
- https://doi.org/10.1097/01.pas.0000126780.10029.f0
Abstract
In recent years, immunohistochemistry has assumed an increasingly prominent role in diagnostic breast pathology. Immunohistochemistry is now frequently used in the evaluation of many epithelial proliferations of the breast. Common applications include the use of myoepithelial markers to evaluate for stromal invasion, E-cadherin to distinguish between ductal and lobular neoplasia, high molecular weight cytokeratins to differentiate usual ductal hyperplasia from ductal carcinoma in situ, immunohistochemical profiles to characterize site of origin of metastatic carcinomas, and cytokeratin stains to detect metastases in sentinel lymph nodes. Recent advances, practical considerations, and potential pitfalls in the use of immunohistochemistry in these five diagnostic categories are discussed herein.Keywords
This publication has 101 references indexed in Scilit:
- Metastases to the breastEuropean Journal of Surgical Oncology, 2003
- Comparison of Pathologist-Detected and Automated Computer-Assisted Image Analysis Detected Sentinel Lymph Node Micrometastases in Breast CancerLaboratory Investigation, 2003
- Expression of Cytokeratins 7 and 20 in Ovarian NeoplasiaAmerican Journal of Clinical Pathology, 2002
- Availability of CD10 Immunohistochemistry as a Marker of Breast Myoepithelial Cells on Paraffin SectionsLaboratory Investigation, 2002
- Cytokeratins 20 and 7 as biomarkersEuropean Journal Of Cancer, 2002
- E-Cadherin Reactivity of 95 Noninvasive Ductal and Lobular Lesions of the BreastAmerican Journal of Clinical Pathology, 2001
- Solid Low-Grade In Situ Carcinoma of the BreastThe American Journal of Surgical Pathology, 2001
- Differential Expression of E-Cadherin in Lobular and Ductal Neoplasms of the Breast and Its Biologic and Diagnostic ImplicationsAmerican Journal of Clinical Pathology, 2001
- Antibodies to Novel Myoepithelium-Associated Proteins Distinguish Benign Lesions and Carcinoma in Situ From Invasive Carcinoma of the BreastApplied Immunohistochemistry & Molecular Morphology, 1997
- TTF-1 gene expression in human lung tumoursEuropean Journal Of Cancer, 1996